Francesco Maria Lavino
Vorstandsvorsitzender bei F2G Ltd.
Aktive Positionen von Francesco Maria Lavino
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | 12.04.2021 | - |
| Vorstandsvorsitzender | 12.04.2021 | - | |
| F2g Inc. | Direktor/Vorstandsmitglied | - | - |
| Präsident | - | - |
Karriereverlauf von Francesco Maria Lavino
Ehemalige bekannte Positionen von Francesco Maria Lavino
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01.09.2015 | 01.07.2017 |
| CUBIST PHARMACEUTICALS INC | Vertrieb & Marketing | 01.12.2013 | 01.09.2015 |
| MERCK & CO., INC. | Direktor/Vorstandsmitglied | 01.01.2011 | 01.11.2013 |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 10.07.2017 | - |
Ausbildung von Francesco Maria Lavino
| Università degli Studi di Napoli Federico II | Undergraduate Degree |
| SDA Bocconi School of Management | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
| Italien | 3 |
| Irland | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NABRIVA THERAPEUTICS PLC | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
| F2g Inc. |
- Börse
- Insiders
- Francesco Maria Lavino
- Erfahrung
